Participating Faculty: Metastatic Colorectal Cancer: Considerations for Treatment in the Third Line and Beyond

Faculty

Afsaneh Barzi, MD, PhD

Associate Professor

GI Oncology

City of Hope

Vice President of Quality and Value

Access Hope

Duarte, CA

Tanios Bekaii-Saab, MD

Director

Department of Hematology and Medical Oncology

Mayo Clinic

Phoenix, AZ

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Afsaneh Barzi, MD, PhD

CONSULTANCIES OR PAID ADVISORY BOARDS

Bayer US, LLC

Travel Support FOR MEETING/CONFERENCE ATTENDANCE

European Society for Medical Oncology 2023 — Travel support provided by Bayer US, LLC.

Tanios Bekaii-Saab, MD

PERSONAL CONFLICTS OF INTEREST

CONSULTING

Abbvie, Inc; Aptitude Health; AstraZeneca; BeiGene, Inc; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc; Celularity Inc; Daiichi Sankyo Company Limited; Deciphera Pharmaceuticals, Inc; Exact Sciences Corporation; Exelixis, Inc; Foundation Medicine, Inc; GSK plc; Illumina, Inc; Janssen Global Services, LLC; Kanaph Therapeutics Inc; Lisata Therapeutics, Inc; MJH Life Sciences; Natera, Inc; Sanofi, Swedish Orphan Biovitrum AB; Stemline Therapeutics, Inc; Treos Bio Limited; Xilio Therapeutics; Zai Lab

SCIENTIFIC ADVISORY BOARD

Artiva Biotherapeutics, Inc; AstraZeneca; Eisai Co, Ltd; Exelixis, Inc; FibroGen, Inc; Immuneering Corporation; Imugene Limited; Kintor Pharmaceutical Limited; Merck & Co, Inc; Pancreatic Cancer Action Network; Replimune Group Inc; Sun Pharmaceutical Industries Ltd; Valley Health System; Xilis; 1Globe Health

ROYALTIES

UpToDate, Inc.

INVENTIONS/PATENTS

18/183,488: Human PD1 peptide vaccines and uses thereof.

19/055,687: Methods and compositions for the treatment of cancer cachexia.

INSTITUTIONAL CONFLICTS OF INTEREST

RESEARCH FUNDING

Agios Pharmaceuticals, Inc; Arcus Biosciences, Inc; Arys Medical; Atreca, Inc; Bayer US, LLC; Boston Biomedical, Inc; Bristol Myers Squibb Company; Celgene Corporation; Clovis Oncology, Inc; Eisai Co, Ltd; Genentech, Inc; Incyte; Ipsen Pharma; Lilly; Merus; Mirati Therapeutics, Inc; Novartis AG, Pfizer Inc; Seagen Inc.

CONSULTING

Arcus Biosciences, Inc; Bayer US, LLC; Eisai Co, Ltd; Genentech, Inc; Incyte; Ipsen Pharma; Merck & Co, Inc; Merck KGaA; Merus; Pfizer Inc; Les Laboratoires Servier; Seagen Inc.